PATENT CLAIM ANALYSIS

Application Number: 15770369
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["514", "255050"]

Abstract:
Described are methods of use of compounds that inhibit PIF-mediated substrate binding by PDK1, which are useful as inhibitors of cancer growth or proliferation that is RSK2-dependent or AKT-independent. Also described are compositions of such compounds for use in such methods of treating cancer.

Claim (Index 5):
The method of  claim 4 , in which the compound is of Formula Iz: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 91.0
- Lexical Diversity: 1.42424
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14966821', '10949714', '10350806', '13124773', '10922575']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8298298382462653
- 35 USC 102 Novelty (BERT): 0.547767347432594
- Combined Prediction Score: 0.8016235891648982
- Mean Citation Score: 397.804354
- Max Citation Score: 416.61884
- Similarity Product: 303.48472766387937

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test